Targeting the Right Ventricle in Pulmonary Hypertension

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This study is looking to see if giving ranolazine to subjects on stable pulmonary hypertension specific therapies but with right ventricular dysfunction (RVEF \<45%) would improve their outcome. This study is accompanied by a baseline comparison of the metabolic profiling/microRNA/iPS cells of subjects with and without right ventricular dysfunction.
Epistemonikos ID: 5c5003463fd674d32f4121361e9083ffe9e08fef
First added on: May 11, 2024